Skip to content

Talis Biomedical Corporation

CIK 0001584751

← back to feed
Revenue (TTM)
$794K
−55.7% YoY Q2 Aug 2024
Net Income (TTM)
−$52.6M
+45.1% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$28.90
+45.6% YoY Q2 Aug 2024
Gross Margin
-162.0%
Q2 Aug 2024
Operating Margin
-7,186.0%
Q2 Aug 2024
Net Margin
-6,624.7%
Q2 Aug 2024
Free Cash Flow (TTM)
−$90.36M
Q2 Aug 2024
Cash
$59.87M
Q2 Aug 2024
Total Debt
—
Q2 Aug 2024
Shares Outstanding
31.69M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings